Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Huizinga Robert Bindert
EVP of Research at Aurinia Pharmaceuticals. Filing since 7 Sep 2021.
CIK 0001837648
Company
Date
Role
Action
Shares
Amount
Of holding
AUPH
Aurinia Pharmaceuticals Inc.
2 Mar 2022
EVP of Research
Sold, plan not stated
4,849
$58.24K
6.5%
AUPH
Aurinia Pharmaceuticals Inc.
25 Oct 2021
EVP of Research
Sold, plan not stated
130,000
$3.87M
66.4%
AUPH
Aurinia Pharmaceuticals Inc.
21 Sep 2021
EVP of Research
Sold, plan not stated
32,500
$779.53K
24.4%
AUPH
Aurinia Pharmaceuticals Inc.
14 Sep 2021
EVP of Research
Sold, plan not stated
22,500
$489.38K
17.5%
AUPH
Aurinia Pharmaceuticals Inc.
10 Sep 2021
EVP of Research
Sold, plan not stated
10,000
$197.95K
7.2%
AUPH
Aurinia Pharmaceuticals Inc.
7 Sep 2021
EVP of Research
Sold, plan not stated
5,000
$91.50K
3.5%
6 decisions on file.
